The study of modern trends in the development of digital logistics in the pharmaceutical industry

Abstract

Aim. To analyze the current trends in the field of digitalization of pharmaceutical logistics and supply chain management in the context of the coronavirus pandemic and identify factors that hinder the introduction of digital technologies into the activities of pharmaceutical market entities.
 Materials and methods. To achieve the goal of the study, an analysis of foreign and domestic scientific literature, an expert survey of managers and employees of pharmaceutical companies was conducted. The research methods were abstract-logical, monographic, system and content analysis, expert survey.
 Results. The relevance of digitalization of pharmaceutical logistics and supply chain management in the context of the coronavirus pandemic has been substantiated. A review of the practice of implementing digital technologies in the activities of domestic pharmaceutical companies has been conducted. According to the expert survey, the problems of introducing digital technologies into the activities of pharmaceutical companies from the point of view of managers and the staff have been identified. The reasons that hinder the process of introducing modern digital technologies into the activities of the domestic pharmaceutical sector in the field of healthcare have been determined.
 Conclusions. The use of digital technologies is a necessary element of restructuring the information and logistics support for all participants in pharmaceutical supply chains, improving the reliability and quality of their activities and protecting the chains from counterfeit products. This problem is especially relevant in a pandemic when a well-organized and uninterrupted pharmaceutical logistics becomes in many cases an important condition for preserving not only health, but also human life. Therefore, today it is necessary to implement a comprehensive system of measures aimed at increasing the level of digitalization of the pharmaceutical industry, which will contribute to increasing the efficiency of the functioning of pharmaceutical supply chains, as well as improving the reliability and continuity of drug supply to the population of Ukraine.